101 results on '"Vervloet, M.G."'
Search Results
2. [Estimating glomerular filtration rate].
3. Clinical utility of bone markers in various diseases
4. 13 Het renale systeem
5. Lower accuracy of testosterone, cortisol, and free T4 measurements using automated immunoassays in people undergoing hemodialysis.
6. Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?.
7. Vitamin D supplementation in people with chronic kidney disease.
8. Prevalence of chronic kidney disease in the Netherlands and its cardiovascular and renal complications.
9. Magnesium to prevent kidney disease-associated vascular calcification: crystal clear?
10. Magnesium in chronic haemodialysis (MAGIC-HD): a study protocol for a randomised controlled trial to determine feasibility and safety of using increased dialysate magnesium concentrations to increase plasma magnesium concentrations in people treated with haemodialysis.
11. Dietary magnesium supplementation inhibits abdominal vascular calcification in an experimental animal model of chronic kidney disease.
12. Magnesium: A Magic Bullet for Cardiovascular Disease in Chronic Kidney Disease?
13. Influence of exogenous growth hormone administration on circulating concentrations of -klotho in healthy and chronic kidney disease subjects: a prospective, single-center open case-control pilot study
14. Routine hemodialysis induces a decline in plasma magnesium concentration in most patients: a prospective observational cohort study
15. Fluid balance-adjusted creatinine at initiation of continuous venovenous hemofiltration and mortality. A post-hoc analysis of a multicenter randomized controlled trial.
16. FGF23 impairs peripheral microvascular function in renal failure
17. Fibroblast growth factor 23 modifies the pharmacological effects of angiotensin receptor blockade in experimental renal fibrosis.
18. Abdominal aortic calcification in patients with CKD
19. Chronic kidney disdaese disturbs cardiac calcium handling due to high FGF23 levels FGF23 levels
20. Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue
21. Pro: Cardiovascular calcifications are clinically relevant
22. alpha-Klotho is unstable in human urine
23. Reduction of Oxidative Stress in Chronic Kidney Disease Does Not Increase Circulating alpha-Klotho Concentrations.
24. Mineral handling in kidney disease. The role of ion transporters and klotho
25. Reversing arterial stiffness and calcification; A pipe dream?
26. Bone: A new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders
27. Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients
28. Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
29. Shedding of klotho by ADAMs in the kidney.
30. Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure
31. Serum magnesium and sudden death in European hemodialysis patients
32. ASSOCIATION OF MAGNESIUM LEVEL WITH REDUCED CARDIOVASCULAR MORTALITY IN INCIDENT DIALYSIS PATIENTS
33. Chronische botpijn door verhoogde FGF23-productie? Het belang van een fosfaatbepaling
34. Laboratory aspects of circulating alpha-Klotho
35. Managing disorders of bone and mineral metabolism in chronic kidney disease
36. 7'Real-World' use of cinacalcet for managing SHPT in different European countries: analysis of data from the ECHO observational study
37. The Biobank of Nephrological Diseases in the Netherlands cohort: the String of Pearls Initiative collaboration on chronic kidney disease in the university medical centers in the Netherlands
38. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: A multi-center randomized clinical trial
39. Time-averaged level of fibroblast growth factor-23 and clinical events in chronic kidney disease
40. Fish and omega-3 fatty acid intake in relation to circulating fibroblast growth factor 23 levels in renal transplant recipients
41. Renal Function 5 Years After Open and Endovascular Aortic Aneurysm Repair From a Randomized Trial
42. Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis.
43. Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: an analysis of the MASTERPLAN cohort.
44. PILOTSTUDY TO EVALUATE THE EFFECT OF PHOSPHORUSBINDERS ON FGF23
45. Vascular calcification, phosphate binders, role of vitamin K
46. The Role of FGF23 on Cardiac and Vascular Function in Experimental Chronic Kidney Disease
47. Interaction among kidney disease-specific risk factors for cardiovascular disease
48. DISRUPTED CELLULAR BARRIERS IN KIDNEY FAILURE:The endothelium and the peritoneal membrane
49. Dietary and Pharmacological Modification of FGF23 and Klotho in Patients with Chronic Kidney Disease
50. Anti-inflammatory interventions and biomarker identification in Peritoneal Dialysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.